These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1009703)

  • 61. [Clinical observation on the increase of leukocyte count in leukopenia promoted by diethylester Rubia cordifolia L].
    Zhang ZH
    Zhong Xi Yi Jie He Za Zhi; 1983 Mar; 3(2):98-9. PubMed ID: 6224602
    [No Abstract]   [Full Text] [Related]  

  • 62. [Experience in the use of Selfer for leukopenia].
    Tai Y
    Horumon To Rinsho; 1972 Mar; 20(3):243-6. PubMed ID: 5065703
    [No Abstract]   [Full Text] [Related]  

  • 63. A prospective evaluation of chemohormonal therapy remission maintenance in advanced breast cancer.
    Tormey DC; Gelman R; Band PR; Sears M; Bauer M; Arseneau JC; Falkson G
    Breast Cancer Res Treat; 1981; 1(2):111-9. PubMed ID: 7348567
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Life with cytostatic drugs.
    Van Dam FS; Linssen AC; Engelsman E; van Benthem J; Hanewald GJ
    Eur J Cancer (1965); 1980; Suppl 1():229-33. PubMed ID: 6947892
    [No Abstract]   [Full Text] [Related]  

  • 65. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
    Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
    Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Anabolic treatment combined with an antimitotic agent in order to prevent leukocyte decrease].
    Biedermann C; Obolensky W; Scoglio P; Zürcher WO
    Ther Umsch; 1966 Dec; 23(12):509-15. PubMed ID: 5980438
    [No Abstract]   [Full Text] [Related]  

  • 68. The effect of nandrolone decanoate on bone marrow suppression induced by cytostatic agents.
    Huys J; Van Vaerenbergh PM
    Clin Oncol; 1976 Sep; 2(3):207-14. PubMed ID: 1009703
    [No Abstract]   [Full Text] [Related]  

  • 69. [Cytostatic therapy: neurologic and psychiatric syndromes].
    Strian F; Maurach R
    Med Klin; 1980 Jun; 75(13):478-84. PubMed ID: 6997713
    [No Abstract]   [Full Text] [Related]  

  • 70.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.